Biocomposite based on reduced graphene oxide film modified with phenothiazone and flavin adenine dinucleotide-dependent glucose dehydrogenase for glucose sensing and biofuel cell applications

Anal Chem. 2015 Oct 6;87(19):9567-71. doi: 10.1021/acs.analchem.5b02949. Epub 2015 Sep 4.

Abstract

A novel composite material for the encapsulation of redox enzymes was prepared. Reduced graphene oxide film with adsorbed phenothiazone was used as a highly efficient composite for electron transfer between flavin adenine dinucleotide (FAD)-dependent glucose dehydrogenase and electrodes. Measured redox potential for glucose oxidation was lower than 0 V vs Ag/AgCl electrode. The fabricated biosensor showed high sensitivity of 42 mA M(-1) cm(-2), a linear range of glucose detection of 0.5-12 mM, and good reproducibility and stability as well as high selectivity for different interfering compounds. In a semibiofuel cell configuration, the hybrid film generated high power output of 345 μW cm(-2). These results demonstrate a promising potential for this composition in various bioelectronic applications.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Biocompatible Materials / chemistry
  • Biocompatible Materials / metabolism
  • Bioelectric Energy Sources*
  • Biosensing Techniques*
  • Electrodes
  • Flavin-Adenine Dinucleotide / metabolism*
  • Glucose / analysis*
  • Glucose / metabolism
  • Glucose 1-Dehydrogenase / metabolism*
  • Graphite / chemistry*
  • Graphite / metabolism
  • Oxidation-Reduction
  • Oxides / chemistry*
  • Oxides / metabolism
  • Phenothiazines / chemistry*
  • Phenothiazines / metabolism

Substances

  • Biocompatible Materials
  • Oxides
  • Phenothiazines
  • Flavin-Adenine Dinucleotide
  • Graphite
  • Glucose 1-Dehydrogenase
  • Glucose